Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2014



	For the Three Months Ended June 30,
		CAG	Water		LPD		Other		Unallocated Amounts		Consolidated Total
2014
Revenue	$	326,697	$	24,487	$	32,739	$	6,199	$	-	$	390,122

Income (loss) from operations	$	70,348	$	10,064	$	7,323	$	(249)	$	(4,267)	$	83,219
Interest expense, net												(2,477)
Income before provision for income taxes												80,742
Provision for income taxes												23,498
Net income												57,244
Less: Net income attributable to noncontrolling interest												26
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	57,218

2013
Revenue	$	295,834	$	22,384	$	28,278	$	6,087	$	-	$	352,583

Income from operations	$	63,358	$	9,913	$	3,215	$	841	$	1,436	$	78,763
Interest expense, net												(735)
Income before provision for income taxes												78,028
Provision for income taxes												24,029
Net income												53,999
Less: Net income attributable to noncontrolling interest												4
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	53,995



	For the Six Months Ended June 30,
		CAG	Water		LPD		Other		Unallocated Amounts		Consolidated Total
2014
Revenue	$	628,285	$	45,908	$	64,090	$	12,042	$	-	$	750,325

Income (loss) from operations	$	126,212	$	18,180	$	13,783	$	340	$	(5,250)	$	153,265
Interest expense, net												(4,780)
Income before provision for income taxes												148,485
Provision for income taxes												44,648
Net income												103,837
Less: Net income attributable to noncontrolling interest												34
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	103,803

2013
Revenue	$	572,774	$	43,050	$	56,317	$	12,547	$	-	$	684,688

Income (loss) from operations	$	114,666	$	18,268	$	8,051	$	1,276	$	(2,312)	$	139,949
Interest expense, net												(1,125)
Income before provision for income taxes												138,824
Provision for income taxes												39,959
Net income												98,865
Less: Net income attributable to noncontrolling interest												11
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	98,854

Summary Of Revenue By Product And Service Category


	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
		2014		2013		2014		2013
CAG segment revenue:
CAG Diagnostics recurring revenue:	$	281,596	$	253,256	$	540,370	$	492,826
IDEXX VetLab® consumables		89,113		78,776		173,434		154,561
VetLab service and accessories		13,512		12,506		26,616		24,559
Rapid assay products		49,493		46,057		92,552		90,140
Reference laboratory diagnostic and consulting services		129,478		115,917		247,768		223,566
CAG Diagnostics capital - instruments		18,914		20,755		37,468		36,587
Customer information management and digital imaging systems		26,187		21,823		50,447		43,361
CAG segment revenue		326,697		295,834		628,285		572,774

Water segment revenue		24,487		22,384		45,908		43,050
LPD segment revenue		32,739		28,278		64,090		56,317
Other segment revenue		6,199		6,087		12,042		12,547
Total revenue	$	390,122	$	352,583	$	750,325	$	684,688

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details